News - PDCI Market Access

12

Jun2019

Final report from the Advisory Council on the Implementation of National Pharmacare

June 12, 2019 / Health Canada, National Pharmacare, News, What's New

On June 6th, 2019, Dr. Eric Hoskins, Chair of the Advisory Council on the Implementation of National Pharmacare, along with ... Read More

24

May2019

CADTH Releases Pharmaceutical Review Update 8

May 24, 2019 / CADTH, CDR, pCODR, What's New

CADTH’s Pharmaceutical Review Updates are used to communicate new CDR and pCODR drug review processes updates to the public. PDCI ... Read More

15

May2019

Status Summary Of Innovative Medicine pCPA Negotiations As Of April 30, 2019

May 15, 2019 / pCPA, What's New

Each month the pCPA issues an update on the previous month’s negotiation activity. In Table 1 below you will find ... Read More

19

Mar2019

Federal Budget 2019 Supporting the Creation of a Canadian Drug Agency

March 19, 2019 / National Pharmacare, What's New

Bill Morneau released his fourth Federal Budget in the House of Commons at 4pm today. Year in Review: In 2018, the federal ... Read More

14

Mar2019

Status Summary of Innovative Medicine pCPA Negotiations as of February 28, 2019

March 14, 2019 / pCPA, What's New

Each month the pCPA issues an update on the previous month’s negotiation activity. In Table 1 below you will find ... Read More

05

Mar2019

Health Canada and CADTH launch new initiative to provide Early Parallel Scientific Advice

March 5, 2019 / CADTH, pCODR, What's New

On February 28, 2019, Health Canada and CADTH, with INESSS participating as an observer, announced a new joint Early ... Read More

22

Feb2019

CADTH Pharmaceutical Reviews Update – Issue 5

February 22, 2019 / CADTH, CDR, pCODR, What's New

CADTH is launching a new Patient and Community Advisory Committee After talks with patient groups this past fall, CADTH is creating ... Read More

15

Feb2019

Status Summary of Innovative Medicine pCPA Negotiations as of January 31, 2019

February 15, 2019 / pCPA, What's New

The Office of the pan-Canadian Pharmaceutical Alliance (pCPA) assesses brand name drug products for public funding either collectively or individually ... Read More